Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background Observational studies have suggested an increased risk of intracranial hemorrhage (ICH) associated with selective serotonin reuptake inhibitors (SSRIs) and other antidepressants primarily inhibiting serotonin reuptake. Objectives Our aim was to systematically review the available epidemiologic evidence regarding the risk of ICH associated with SSRIs and antidepressants inhibiting serotonin reuptake. Methods MEDLINE/PubMed and EMBASE were searched for all relevant articles in English, French, or German published before April 2017. Observational studies with SSRIs or any antidepressants classified by strength of serotonin reuptake inhibition as primary exposure, a comparison group, and ICH as outcome were eligible. Results Among twelve identified studies (six nested case-control, three cohort, two case-control, one case-crossover), seven assessed the risk of ICH associated with SSRIs (some also including other antidepressants primarily inhibiting serotonin reuptake), two the risk of ICH associated with inhibitors of serotonin reuptake according to the degree of reuptake inhibition, and three addressed both objectives. Four of ten studies showed an increased risk of ICH associated with SSRIs, with the two largest studies suggesting a moderate effect. Three of five studies showed an increased risk of ICH associated with strong inhibitors of serotonin reuptake. Limitations including residual confounding, inclusion of prevalent users, potentially inappropriate study desi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lack of broad scale studies may be attributed in part to the heterogeneity and complexity of the phenomenon itself, and the lack of standardized data publicly available5–6.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [6]
In the citing paper
“However, few machine-readable databases of ADEs exist, limiting our capacity to study drug safety on a broader, systematic scale.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [6]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“This systematic review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [18], and following a prespecified protocol.”
MethodPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“Screening of titles and abstracts for articles potentially eligible for further review was performed independently by two investigators (AD and CR) in accordance with the PRISMA checklist [19].”
MethodLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events
Maclure, M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115853 · Cited by 2,327 · cited 1×
“Importantly, the study with the highest point estimate used a case-crossover design [17], which was developed for transient exposures and not for drugs often taken on a regular basis such as SSRIs [29].”
BackgroundOveradjustment bias and unnecessary adjustment in epidemiologic studies.
Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096 · cited 1×
“Second, adjusting for covariates at cohort entry may become complicated, since some of these covariates could be affected by the drug itself and thus be in the causal pathway; such overadjustment has been shown to increase bias [33, 34].”
BackgroundEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · cited 2×
“Second, adjusting for covariates at cohort entry may become complicated, since some of these covariates could be affected by the drug itself and thus be in the causal pathway; such overadjustment has been shown to increase bias [33, 34].”
BackgroundPharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939 · cited 2×
“Importantly, the strength of serotonin reuptake inhibition varies among different SSRIs and antidepressants in general [9].”
BackgroundLund, J. L., Richardson, D. B., & Stürmer, T. (2015) · Current Epidemiology Reports · doi:10.1007/s40471-015-0053-5 · Cited by 739 · cited 1×
“While the use of an active comparator has been suggested in order to decrease the impact of this bias and especially indication bias [30], only three studies compared SSRIs with other classes of antidepressants [15, 27], or compared strong with weak inhibitors of serotonin reuptake [13, 15].”
Cited by
Greenberg, S. M., Ziai, W. C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J. N., Hemphill, J. C., Johnson, R., Keigher, K. M., Mack, W. J., et al. (2022) · Stroke · doi:10.1161/str.0000000000000407 · Cited by 1,639
Ziai, W., & Carhuapoma, J. R. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000672 · Cited by 170
Nochaiwong, S., Ruengorn, C., Awiphan, R., Chai‐Adisaksopha, C., Tantraworasin, A., Phosuya, C., Kanjanarat, P., Chongruksut, W., Sood, M. M., & Thavorn, K. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.2017474 · Cited by 99
Rahman, A. A., Platt, R. W., Beradid, S., Boivin, J., Rej, S., & Renoux, C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3208 · Cited by 70
Self-citationClinically relevant drug interactions between newer antidepressants and oral anticoagulants
Spina, E., Barbieri, M. A., Cicala, G., Bruno, A., & de León, J. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1700952 · Cited by 47
Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors
Pressman, E., Penn, D. L., & Patel, N. J. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.10.173 · Cited by 31
Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study
Douros, A., Dell’Aniello, S., Dehghan, G., Boivin, J., & Renoux, C. (2019) · Neurology · doi:10.1212/wnl.0000000000008060 · Cited by 28
“Indeed, inhibition of serotonin transport back into thrombocytes can interfere with their function,(12) and antidepressants strongly inhibiting serotonin reuptake have been associated with an increased risk of major bleeding such as gastrointestinal bleeding(13) and intracranial hemorrhage.(14,15) Thus, it has also be…”
BackgroundSelf-citationAntidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study
Schäfer, W., Princk, C., Kollhorst, B., & Schink, T. (2019) · Drug Safety · doi:10.1007/s40264-019-00837-y · Cited by 20
Tanaka, Y., Chen, H. Y., Belloni, P., Gisladottir, U., Kefeli, J., Patterson, J., Srinivasan, A., Zietz, M., Sirdeshmukh, G., Berkowitz, J., et al. (2025) · Med · doi:10.1016/j.medj.2025.100642 · Cited by 17
Zeiss, R., Connemann, B. J., Schönfeldt‐Lecuona, C., & Gahr, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727687 · Cited by 16
Chen, X., Li, C., Jin, D., Ingram, B. O., Hao, Z., Bai, X., Stafford, D. W., Hu, K., & Tie, J. (2020) · Blood · doi:10.1182/blood.2019004234 · Cited by 13
Overvad, T. F., Andersen, S. D., Larsen, T. B., Lip, G. Y. H., Søgaard, M., Skjøth, F., & Nielsen, P. B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.03.024 · Cited by 12
Rahman, A. A., He, N., Rej, S., Platt, R. W., & Renoux, C. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1932-8976 · Cited by 13
Self-citationAntidepressant drug use and subdural hematoma risk
Gaist, D., Rodríguez, L. A. G., Hald, S. M., Hellfritzsch, M., Poulsen, F. R., Halle, B., Hallas, J., & Pottegård, A. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14658 · Cited by 12
Effects of selective serotonin reuptake inhibitors on platelet functions: a literature review
Mokhtarian, A., Siguret, V., & Jourdi, G. (2024) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000847 · Cited by 11
Clinical Implications of Antidepressants and Associated Risk of Bleeding: A Narrative Review
Kaye, A. D., Cooper, H. D., Mashaw, S. A., Anwar, A. I., Hollander, A. V., Thomassen, A. S., Singh, A., & Shekoohi, S. (2025) · Current Pain and Headache Reports · doi:10.1007/s11916-025-01412-0 · Cited by 9
“Observational studies and case reports have highlighted increased risks of gastrointestinal (GI) bleeding [ 5 ], intra-cranial hemorrhages [6], and perioperative bleeding [7] in patients taking SSRIs and SNRIs.”
Neurobiological Mechanisms Underlying Psychological Dysfunction After Brain Injuries
Unadkat, P., Rebeiz, T. J., Ajmal, E., Souza, V. D., Xia, A., Jinu, J., Powell, K., & Li, C. (2025) · Cells · doi:10.3390/cells14020074 · Cited by 9
Mortensen, J. K., & Andersen, G. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.1986001 · Cited by 12
“findings from recent case-control studies [42,43] a recent systematic review [44] and two recent meta-analyses [45,46] found an association between SSRI treatment and an increased risk of intracranial hemorrhage.”
ResultZabolotskikh, I. B., Gritsan, A. I., Лебединский, К. М., Myasnikova, V. V., Муронов, А. Е., & Шаповалов, К. Г. (2021) · Annals of critical care · doi:10.21320/1818-474x-2021-1-19-47 · Cited by 9
“Установлено, что прием СИОЗС ассоциирован с повышением риска возникновения внутричерепных кровоизлияний [15, 142, 143].”
Corriere, M. A., Dickson, A. L., Daniel, L. L., Nepal, P., Hall, K., Plummer, W. D., Dupont, W. D., Murray, K. T., Stein, C., Ray, W. A., et al. (2023) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000001105 · Cited by 9
Depression and Anxiety Disorders
Karamustafalıoğlu, O., & Yumrukçal, H. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg003.pub2 · Cited by 8
Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding
Isokuortti, H., Iverson, G. L., Posti, J. P., Ruuskanen, J. O., Brander, A., Kataja, A., Nikula, M., Öhman, J. E., & Luoto, T. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.758707 · Cited by 6
Gahr, M., Connemann, B. J., Muche, R., & Zeiss, R. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001411 · Cited by 6
Smithson, J., & Mitchell, P. B. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.10.002 · Cited by 6
Platelet function defects and sertraline‐induced bleeding: a case report
Strumia, M., Guerrero, F., Ribes, A. M., Garcia, C., Payrastre, B., & Bagheri, H. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12552 · Cited by 5
Silveira, J. B., Damiano, R. F., Neto, E. A., Gomes, R. N. D. S. M., Klein, I., Borrione, L., Sudbrack-Oliveira, P., Gentil, A. F., Shephard, E., Brunoni, A. R., et al. (2022) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2556 · Cited by 5
Yayan, J., & Rasche, K. (2025) · Neurology International · doi:10.3390/neurolint17070111 · Cited by 4
Lekander, I., von Euler, M., & Sunnerhagen, K. S. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036159 · Cited by 4
Esmaili, H., Asl, N. S., Ghorbani, R., & Maheri, M. (2024) · Practice in Clinical Psychology · doi:10.32598/jpcp.12.1.899.1 · Cited by 2
Chapter 20. Psychopharmacology
Mulsant, B. H., & Pollock, B. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds20 · Cited by 1
Comparative Cardiovascular Safety of Duloxetine and Gabapentin in Patients with Hip Osteoarthritis
Moon, S., Choo, E., Choi, Y. J., & Shin, S. (2025) · Journal of Pain Research · doi:10.2147/jpr.s557621 · Cited by 1
“18,19 Additionally, its adrenergic effects, stemming from norepinephrine reuptake inhibition, may increase sympathetic nervous system activity, leading to elevated blood pressure and heart rate, further exacerbating CV risks.”
Posti, J. P., Tornio, A., Ruuskanen, J. O., & Kytö, V. (2026) · Neurology · doi:10.1212/wnl.0000000000214602 · Cited by 1
Antidepressants and bleeding risk: Expert consensus from the Association of Medicine and Psychiatry
Robbins-Welty, G. A., Fiedorowicz, J. G., Gensler, L., Chandra, A., Ward, M., Huang, H., Smith, C. M., Lang, M. C., Xiong, G. L., Pinkhasov, A., et al. (2026) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2026.112633 · Cited by 2
Mu, Y., Ma, R., Wang, Q., Wang, X., Gu, S., & Zuo, H. (2026) · Translational Stroke Research · doi:10.1007/s12975-026-01439-4 · Cited by 1
“This dual vascular effect high - lights the complex role of serotonin metabolism in stroke pathogenesis [38].”
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1
Blutungsrisiko unter Antidepressiva mit Hemmung der Serotoninwiederaufnahme
Connemann, B. J., Schönfeldt‐Lecuona, C., Gahr, M., & Zeiss, R. (2018) · Nervenheilkunde · doi:10.1055/s-0038-1675698
“In einer systematischen Übersichtsarbeit zu intrakraniellen Blutungen unter einer Therapie mit SRI wird geschlossen, dass die Datenlage für eine abschließende Bewertung noch unzureichend ist (17).”
BackgroundPerioperative management of patients with mental diseases
Zabolotskikh, I. B., Лебединский, К. М., Myasnikova, V. V., Муронов, А. Е., Шаповалов, К. Г., & Gritsan, A. I. (2018) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology201801-021146
Terceño, M., Serena, J. L., Bashir, S., Vera-Monge, V. A., Puig, J., Blasco, G., Puig, M., & Silva, Y. (2019) · European Neurology · doi:10.1159/000503561
Virale Meningoenzephalitis: eine seltene Ursache der Hyperventilation
Uhlenbruch, M., Bärmann, M.-K., & Krüger, S. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01309-9
Ayerbe, L., Boreu, Q. F., Forgnone, I., Pérez-Piñar, M., Mathur, R., & Ayis, S. A. (2025) · Neurocirugía (English Edition) · doi:10.1016/j.neucie.2025.500738
Ayerbe, L., Boreu, Q. F., Forgnone, I., Pérez-Piñar, M., Rohini, M., & Ayis, S. A. (2025) · Neurocirugía · doi:10.1016/j.neucir.2025.500738
Neto, J. J. D. M., VÉO, J. M., Ricciardi, M. C., & Neto, M. V. (2026) · Research Society and Development · doi:10.33448/rsd-v15i5.51150
Wang, S., YingHua, L., Chen, J., 杨娟, Xu, L., Huang, J., Yin, F., Zheng, Q., & Li, L. (2026) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002909
Metadata
- Authors
- Douros, A., Ades, M., & Renoux, C.
- Affiliations
- Jewish General Hospital (CA)
- McGill University (CA)
- Corresponding author
- Renoux, Christel
- Venue
- CNS Drugs
- Published
- 2018-03-13
- Volume
- 32
- Issue
- 4
- Pages
- 321-334
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W2791111957
- Cited by
- 42
- References
- 37
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 2
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- intracranial hemorrhage, selective serotonin reuptake inhibitors, antidepressants, serotonin reuptake inhibition, drug safety, adverse drug reactions
- MeSH terms
- Antidepressive Agents, Humans, Selective Serotonin Reuptake Inhibitors, Intracranial Hemorrhages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.